FrontPoint Cuts Healthcare Team Amidst Insider-Trading Scandal

Dec 15 2010 | 10:13am ET

Last month, FrontPoint Partners shuttered its healthcare hedge funds in the wake of an insider-trading investigation. And with no more healthcare funds, the embattled firm saw no reason to continue paying its healthcare team.

Greenwich, Conn.-based FrontPoint cut the entire 12-person team working on the funds at the beginning of November, according to published reports. The move came shortly after FrontPoint, which recently spun off from Morgan Stanley, acknowledged that Joseph Skowron, its lead healthcare manager, was the unidentified hedge fund manager named in the criminal complaint against a French doctor.

That doctor, Yves Benhamou, was accused of passing confidential information on the results of a drug trial to at least six hedge funds, among them FrontPoint. While neither the firm nor Skowron have been charged with any wrongdoing, FrontPoint suspended him pending an investigation.

Despite the lack of charges, investors began fleeing the $1.5 billion funds—as well as other FrontPoint funds. The firm has been hit with some $3 billion in redemption requests.

Last week, FrontPoint laid off more than two dozen non-investment staffers as it moves to cut costs in the face of the redemptions. The firm employed 219 people as of the end of September.


In Depth

Q&A: TCA Fund Management's Bob Press on Small-Cap Private Equity

Aug 25 2016 | 8:55pm ET

The emergence of private credit as a replacement for traditional bank financing...

Lifestyle

Kiawah: Island Reversal

Aug 24 2016 | 9:59pm ET

Looking for real estate investments but the typical real estate fare isn’t cutting...

Guest Contributor

Old Hill Partners: Embrace Illiquidity

Aug 9 2016 | 2:39pm ET

The age-old financial concept that higher yields are the result of higher risk and...